Showing results (391-400 of 2,439) with videos related to
Sort By:
Pageof 244
Clinical and Translational Science|February 24, 2023
Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations - A nationwide trialVeroniek E M Harbers, Lilly G J M Zwerink, Gerard A Rongen, et al.Clinical and Translational Science|May 2, 2021
A randomized, double-blind, placebo- and positive-controlled crossover study of the effects of durlobactam on cardiac repolarization in healthy subjectsJohn O'Donnell, Kathleen Maloney, Melissa Steidler, et al.Clinical and Translational Science|May 13, 2021
Opportunities and challenges in translational scienceChristopher P AustinClinical and Translational Science|May 13, 2021
First-in-human trial assessing the pharmacokinetic-pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive ageLars-Erik Broksø Kyhl, Christiane Hesse, Per Larsson, et al.Clinical and Translational Science|May 13, 2021
3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory considerationHongbing Wang, Paul C Brown, Edwin C Y Chow, et al.Clinical and Translational Science|May 13, 2021
Effects of 5-HT₃ receptor antagonists on cisplatin-induced kidney injuryMitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, et al.Clinical and Translational Science|May 23, 2020
Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across AntipsychoticsNoraly Stam, Heidi Taipale, Antti Tanskanen, et al.Clinical and Translational Science|May 23, 2020
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19Dan Hartman, Steven Kern, Fran Brown, et al.Clinical and Translational Science|September 3, 2021
Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomesAhmed El-Boraie, Julie-Anne Tanner, Andy Z X Zhu, et al.Clinical and Translational Science|August 10, 2021
Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participantsHolger Scheible, Martin Dyroff, Annick Seithel-Keuth, et al.Pageof 244